Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT02584933
Title	Roll-over Study to Allow Access to Certinib (LDK378) for Patients Who Are on Ceritinib Treatment in a Novartis-sponsored Study
Recruitment	Active, not recruiting
Gender	both
Phase	FDA approved
Variant Requirements	Yes
Sponsors	Novartis Pharmaceuticals
Indications	Advanced Solid Tumor hematologic cancer
Therapies	Ceritinib
Age Groups:	adult
Covered Countries	USA \| POL \| LBN \| ITA \| FRA \| ESP \| DEU \| CZE \| BRA \| BGR \| BEL \| AUS